While COVID-19 is grinding world economies to a potentially disastrous halt, the pharmaceutical and biotech industry continues to move forward at a slower pace.

How can companies ensure an agile launch despite the uncertainty and ensure launch success during and in a post-COVID-19 world?

Thank you for connecting with Trinity.

Please read TRINITY’s white paper:

Trinity_Launch-in-the-Age-of-COVID-19-Briefing_05.19.20